AmerisourceBergen Corp.

NYS: ABC

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Jun 1, 2020, 6:12 p.m.

ABC
/zigman2/quotes/201066379/composite

$

95.15

Change

0.00 0.00%

Volume

Volume 35,529

Quotes are delayed by 20 min

/zigman2/quotes/201066379/composite

Today's close

$ 95.34

$ 95.15

Change

-0.19 -0.20%

Day low

Day high

$94.84

$95.87

Open

52 week low

52 week high

$72.06

$97.50

Open

James Francis Cleary

James Francis Cleary is Chief Financial Officer & Executive Vice President at AmerisourceBergen Corp. and Member-Board of Managers at Feeders' Advantage LLC and on the board of 6 other companies.

In the past he was Director & Vice President at Agri Beef Co., President, Chief Executive Officer & Director at MWI Veterinary Supply, Inc. and President at MWI Veterinary Supply Co.

Mr. Cleary received an undergraduate degree from Dartmouth College and an MBA from Harvard Business School.

Transactions

Date Shares Transaction Value
11/14/2019 477   Derivative/Non-derivative trans. at $82.33 per share. 39,272
11/14/2019 1,520   Award at $0 per share. 0
11/08/2019 1,079   Derivative/Non-derivative trans. at $86.07 per share. 92,870
11/08/2019 3,439   Derivative/Non-derivative trans. at $0 per share. 0
03/26/2019 6   Acquisition at $76.15 per share. 456
03/21/2019 6   Disposition at $80.3 per share. 482
03/19/2019 6   Acquisition at $81.2 per share. 487
03/06/2019 2,000   Acquisition at $77.52 per share. 155,040
03/05/2019 11   Acquisition at $80.53 per share. 885
12/04/2018 10   Acquisition at $88.44 per share. 884
11/15/2018 802   Derivative/Non-derivative trans. at $92.22 per share. 73,961
11/15/2018 2,554   Award at $0 per share. 0
11/09/2018 144   Derivative/Non-derivative trans. at $88.86 per share. 12,796
11/09/2018 458   Derivative/Non-derivative trans. at $88.86 per share. 40,697
09/05/2018 9   801
08/31/2018 569   Derivative/Non-derivative trans. at $89.97 per share. 51,193
08/31/2018 1,809   Derivative/Non-derivative trans. at $89.97 per share. 162,755
06/05/2018 9   757
03/06/2018 8   755
12/05/2017 9   770
09/06/2017 9   720
06/06/2017 8   741
03/07/2017 8   716
12/06/2016 9   708
09/07/2016 8   704
06/07/2016 9   686
03/08/2016 8   700
12/02/2015 7   700
09/02/2015 6   600
08/11/2015 1,000   Acquisition at $104.88 per share. 104,880
06/02/2015 3   Acquisition at $112.43 per share. 337

Officers and Executives

Mr. Steven H. Collis
Chairman, President & Chief Executive Officer
Mr. James Francis Cleary
Chief Financial Officer & Executive Vice President
Mr. Dale B. Danilewitz
Chief Information Officer & Executive VP
Ms. Gina K. Clark
Chief Communications & Administration Officer, EVP
Ms. Leslie E. Donato
Chief Strategy Officer & Executive Vice President
Mr. Rafael Augusto Kosa Teixeira
Senior Vice President-Transformation
Ms. Kathy Habecker Gaddes
Chief Compliance Officer & Executive Officer
Mr. Sun Park
Executive Vice President
Dr. Robert P. Mauch
EVP & Group President-Pharmaceutical Distribution
Ms. Ornella Barra
Non-Independent Director
Mr. Jack F. Quinn
Treasurer & Vice President
Mr. Lazarus Krikorian
Principal Accounting Officer, SVP & Controller
Mr. Bennett S. Murphy
Vice President-Investor Relations
Ms. Silvana Battaglia
Chief Human Resources Officer & Executive VP
Mr. John G. Chou
Executive VP, Chief Legal Officer & Secretary
Mr. Dennis M. Nally
Independent Director
Mr. Henry Wadsworth McGee
Independent Director
Mr. Richard W. Gochnauer
Independent Director
Dr. Jane Ellen Henney
Lead Independent Director
Ms. Kathleen W. Hyle
Independent Director
Mr. Michael J. Long
Independent Director
Mr. Lon R. Greenberg
Independent Director
Mr. D. Mark Durcan
Independent Director
Link to MarketWatch's Slice.